Todos Medical Announces Launch of Public Offering
Post# of 1418
(Total Views: 350)
Posted On: 07/11/2019 3:46:50 PM
Todos Medical Announces Launch of Public Offering
REHOVOT, Israel, July 11, 2019
(GLOBE NEWSWIRE) --
Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer's disease, today announced that it has launched a roadshow for a public offering of up to $7,000,000 of units. Each unit issued in the offering will consist of one share of common stock and one warrant to purchase one share of common stock. The common stock and warrants will be immediately separable from the units and will be issued separately.
Todos Medical has made an application to list the shares and the warrants on the Nasdaq Capital Market under the ticker symbol “TOMD” and “TOMD.WS”, respectively.
Maxim Group LLC will act as sole book-running manager for the offering.
The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus relating to the offering may be obtained from Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174, at (212) 895-3745.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Read More: https://investorshangout.com/recentnews/TOMDF#ixzz5tOrpu4FJ
REHOVOT, Israel, July 11, 2019
(GLOBE NEWSWIRE) --
Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer's disease, today announced that it has launched a roadshow for a public offering of up to $7,000,000 of units. Each unit issued in the offering will consist of one share of common stock and one warrant to purchase one share of common stock. The common stock and warrants will be immediately separable from the units and will be issued separately.
Todos Medical has made an application to list the shares and the warrants on the Nasdaq Capital Market under the ticker symbol “TOMD” and “TOMD.WS”, respectively.
Maxim Group LLC will act as sole book-running manager for the offering.
The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus relating to the offering may be obtained from Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174, at (212) 895-3745.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Read More: https://investorshangout.com/recentnews/TOMDF#ixzz5tOrpu4FJ
(1)
(0)